These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14631326)

  • 21. Structure and costs of health care of diabetic patients in Finland.
    Kangas T; Aro S; Koivisto VA; Salinto M; Laakso M; Reunanen A
    Diabetes Care; 1996 May; 19(5):494-7. PubMed ID: 8732715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct costs of diabetes mellitus in Germany - CoDiM 2000-2007.
    Köster I; Huppertz E; Hauner H; Schubert I
    Exp Clin Endocrinol Diabetes; 2011 Jun; 119(6):377-85. PubMed ID: 21264804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic Costs of Diabetes in the U.S. in 2017.
    American Diabetes Association
    Diabetes Care; 2018 May; 41(5):917-928. PubMed ID: 29567642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Technology and the issue of cost/benefit in diabetes.
    Giannini C; Mohn A; Chiarelli F
    Diabetes Metab Res Rev; 2009 Sep; 25 Suppl 1():S34-44. PubMed ID: 19662616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in the use and cost of human and analogue insulins in a Colombian population, 2011-2015.
    Torres DR; Portilla A; Machado-Duque ME; Machado-Alba JE
    Public Health; 2017 Dec; 153():64-69. PubMed ID: 28950114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic impact of migraine and other episodic headaches in France: data from the GRIM2000 study.
    Pradalier A; Auray JP; El Hasnaoui A; Alzahouri K; Dartigues JF; Duru G; Henry P; Lantéri-Minet M; Lucas C; Chazot G; Gaudin AF
    Pharmacoeconomics; 2004; 22(15):985-99. PubMed ID: 15449963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct costs in diabetic and non diabetic people: the population-based Turin study, Italy.
    Bruno G; Picariello R; Petrelli A; Panero F; Costa G; Cavallo-Perin P; Demaria M; Gnavi R
    Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):684-90. PubMed ID: 21907553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [COART France 2003 report on new socioeconomic data on osteoarthritis in France].
    Solignac M
    Presse Med; 2004 May; 33(9 Pt 2):S4-6. PubMed ID: 15226681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cost of the treatments of arterial hypertension associated with diabetes].
    Passa P; Giraud S
    Diabete Metab; 1993 Dec; 19(5 Suppl):523-7. PubMed ID: 8206192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Epidemiology and costs of diabetes mellitus in Germany].
    Hauner H
    Dtsch Med Wochenschr; 2005 Jul; 130 Suppl 2():S64-5. PubMed ID: 15988670
    [No Abstract]   [Full Text] [Related]  

  • 31. The direct and indirect cost of diabetes in Italy: a prevalence probabilistic approach.
    Marcellusi A; Viti R; Mecozzi A; Mennini FS
    Eur J Health Econ; 2016 Mar; 17(2):139-47. PubMed ID: 25427540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Determinants of the cost of initiation of insulin therapy type 2 diabetic patients in France: possible approaches to optimization].
    Hanaire H; Attali C; Lecointre B; Fraysse M; Gouet D; Babel MR; Charbonnel B; Sarkozy F; Gourmelen J; Detournay B
    Sante Publique; 2016 Dec; 28(6):781-789. PubMed ID: 28155773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetes--prevalence and cost of illness in Germany: a study evaluating data from the statutory health insurance in Germany.
    Stock SA; Redaelli M; Wendland G; Civello D; Lauterbach KW
    Diabet Med; 2006 Mar; 23(3):299-305. PubMed ID: 16492214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The increase in the use of drug treatment for diabetes mellitus in the Netherlands, 1998-2003].
    Langendam MW; Hooijkaas C; Piepenbrink JF
    Ned Tijdschr Geneeskd; 2006 Jun; 150(25):1396-401. PubMed ID: 16841589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of diabetes mellitus on healthcare costs in Italy.
    Giorda CB; Manicardi V; Diago Cabezudo J
    Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):709-19. PubMed ID: 22098288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and treatment costs of type 2 diabetes in Germany and the effects of social and demographical differences.
    Sittig DT; Friedel H; Wasem J
    Eur J Health Econ; 2015 Apr; 16(3):305-11. PubMed ID: 24619251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors Contributing to the Rising National Cost of Glucose-Lowering Medicines for Diabetes During 2005-2007 and 2015-2017.
    Zhou X; Shrestha SS; Shao H; Zhang P
    Diabetes Care; 2020 Oct; 43(10):2396-2402. PubMed ID: 32737138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [In vitro fertilization in France: economic aspects and influence of the gonadotropin choice (urinary vs. recombinant) on cost].
    de Mouzon J; Allavena E; Schmitt C; Frappé M
    Gynecol Obstet Fertil; 2004 Jun; 32(6):508-18. PubMed ID: 15217566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The human and economic burden of cancer in France in 2014, based on the Sniiram national database].
    Tuppin P; Pestel L; Samson S; Cuerq A; Rivière S; Tala S; Denis P; Drouin J; Gissot C; Gastaldi-Ménager C; Fagot-Campagna A
    Bull Cancer; 2017 Jun; 104(6):524-537. PubMed ID: 28285755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Economic consequences of diabetes mellitus in the U.S. in 1997. American Diabetes Association.
    Diabetes Care; 1998 Feb; 21(2):296-309. PubMed ID: 9539999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.